Halozyme Therapeutics shares owned by EverPoint Asset Management
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by EverPoint Asset Management
from 13F filings
Historical chart of EverPoint Asset Management investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by EverPoint Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Halozyme Therapeutics by EverPoint Asset Management
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2016-12-31 | $6.9M | 700k | 9.88 |
More positions owned by EverPoint Asset Management
View all positions for EverPoint Asset Management